These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 11488752

  • 1. The management of intractable haematuria.
    Kouriefs C, Gordon SJ.
    BJU Int; 2001 Aug; 88(3):301-2. PubMed ID: 11488752
    [No Abstract] [Full Text] [Related]

  • 2. A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients.
    Khojasteh NH, Zakerinia M, Ramzi M, Haghshenas M.
    Transplant Proc; 2000 May; 32(3):596. PubMed ID: 10812128
    [No Abstract] [Full Text] [Related]

  • 3. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data).
    Hows J, Mehta A, Gordon-Smith EC.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():53-6. PubMed ID: 6414696
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H.
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [Abstract] [Full Text] [Related]

  • 5. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
    Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL.
    J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
    Grañena A, Gardella S, Marín P, Carreras E, Montserrat E, Rozman C.
    Sangre (Barc); 1986 Nov; 31(3):307-10. PubMed ID: 3092373
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia.
    Blacklock H, Ball L, Knight C, Schey S, Prentice G.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():45-52. PubMed ID: 6414695
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy.
    Haselberger MB, Schwinghammer TL.
    Ann Pharmacother; 1995 Sep; 29(9):918-21. PubMed ID: 8547741
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemorrhagic cystitis, chemotherapy, and bladder toxicity.
    Ratliff TR, Williams RD.
    J Urol; 1998 Mar; 159(3):1044. PubMed ID: 9474228
    [No Abstract] [Full Text] [Related]

  • 17. Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study.
    Saito Y, Kumamoto T, Shiraiwa M, Sonoda T, Arakawa A, Hashimoto H, Tamai I, Ogawa C, Terakado H.
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e460-e464. PubMed ID: 29989294
    [Abstract] [Full Text] [Related]

  • 18. Hemorrhagic cystitis complicating bone marrow transplantation.
    Letendre L, Hoagland HC, Gertz MA.
    Mayo Clin Proc; 1992 Feb; 67(2):128-30. PubMed ID: 1545575
    [Abstract] [Full Text] [Related]

  • 19. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.
    Link H, Neef V, Niethammer D, Wilms K.
    Blut; 1981 Nov; 43(5):329-30. PubMed ID: 6799018
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.